Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2007-11-27
2007-11-27
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
Reexamination Certificate
active
09701450
ABSTRACT:
Disclosed are compositions comprising antiseptic and wound healing agents for the treatment of diseases of the lower respiratory tract and methods.
REFERENCES:
patent: 2706701 (1955-04-01), Beller et al.
patent: 4113857 (1978-09-01), Shetty
patent: 4235871 (1980-11-01), Papahadjopoulous et al.
patent: 4560678 (1985-12-01), Ranson
patent: 4675009 (1987-06-01), Hymes et al.
patent: 4704383 (1987-11-01), McNamara et al.
patent: 4906476 (1990-03-01), Radhakrishnan
patent: 4938965 (1990-07-01), Shek et al.
patent: 5006343 (1991-04-01), Benson et al.
patent: 5034228 (1991-07-01), Meybeck et al.
patent: 5049388 (1991-09-01), Knight
patent: 5049389 (1991-09-01), Radhakrishnan
patent: 5114928 (1992-05-01), Gajdos et al.
patent: 5128139 (1992-07-01), Brown et al.
patent: 5232692 (1993-08-01), Isenberg et al.
patent: 5246708 (1993-09-01), von Borstel et al.
patent: 5290540 (1994-03-01), Prince
patent: 5456923 (1995-10-01), Nakamichi et al.
patent: 5552158 (1996-09-01), Evans et al.
patent: 5942245 (1999-08-01), Katinger et al.
patent: 1 323 568 (1993-10-01), None
patent: 2 204 493 (1996-05-01), None
patent: 2 332 389 (1999-05-01), None
patent: 2 215 716 (1999-07-01), None
patent: 0260241 (1988-03-01), None
patent: 0 267 050 (1988-05-01), None
patent: 0317405 (1989-05-01), None
patent: 0404028 (1991-01-01), None
patent: 0509338 (1992-10-01), None
patent: 0613685 (1994-09-01), None
patent: 0639373 (1995-02-01), None
patent: 1 013 269 (2000-06-01), None
patent: 1013269 (2000-06-01), None
patent: 02-204413 (1990-08-01), None
patent: 2204413 (1990-08-01), None
patent: 7-145081 (1995-06-01), None
patent: 63126820 (1998-05-01), None
patent: 85/00112 (1985-01-01), None
patent: WO 87/07502 (1987-12-01), None
patent: WO 88/01862 (1988-03-01), None
patent: 8809165 (1988-12-01), None
patent: 9324165 (1988-12-01), None
patent: 9011781 (1990-10-01), None
patent: WO 91/16882 (1991-11-01), None
patent: WO 92/13873 (1992-08-01), None
patent: 9414490 (1994-07-01), None
patent: 9428876 (1994-12-01), None
patent: 9614083 (1996-05-01), None
patent: WO 96/19199 (1996-06-01), None
patent: WO 96/22764 (1996-08-01), None
patent: WO 96/35435 (1996-11-01), None
patent: WO 98/05340 (1998-02-01), None
patent: 9960998 (1999-12-01), None
patent: 9961003 (1999-12-01), None
patent: 0072823 (2000-12-01), None
patent: WO00/72822 (2000-12-01), None
Chemical Abstracts, vol. 117, No. 10 (Sep. 7, 1992); Abstract No. 97244, Brian E. Gilbert et al.,Aerosolized Liposomal Amphotericin B for Treatment of Pulmonary and Systemic Cryptococcus Neoformans Infections in Mice, 36(7) Antimicrob. Agents Chemotherapy 1466-71 (1992).
Abstract EP 0613685 (English).
Abstract EP 0509338 (English).
Janine F. Bridges, et al., “The Uptake of Liposome-Entrapped I-Labelled Poly(Vinyl Pyrrolidone)By Rat Jejunum In-Vitro,” Biochemica et Biophycica Acta, 544 (1978) 448-451.
Peter M. Vogt, et al. “Polyvinyl pyrrolidone-iodine Lipsome Hydrogel Improves Epithelialization By Combing Moisture and Antisepsis. A New Concept In Wound Therapy,” Wound Repair and Regeneration vol. 9. No. 2 p. 116-112.
Karen Reimer, et al., “An Innovative Topical Drug Formulation for Wound Healing And Infection Treatment: In-Vitro and In-Vivo Investigations of a Povidone-Iodine Liposome Hydrogel,” Dermatology 2000, 201: 235-241.
Jenny Liautard, et al. “Encapulation of Drugs Into Large Unilamellar Liposomes Prepared by an Extemposaneous Method,” J. Microencapsulation, 1991, vol. 8, No. 3, 381-89.
Abstract JP 22 04413 and Jp 63-126 820 (English).
P. Würzler, et al., “Virucidal and Chlamudicidal Activites of Povidone-Iodine (PVP-1) Lipsomes,” Clin Microbial Inf 5(suppl 3) 136 (1990) 9thEuropean Conference of Clin Microbiology and Infectious Diseases, Berlin, Mar. 99.
Bernhard Müllinger, et al., “Coated Drug Droplets Allow Individual Dosimetry,” Respiratory Drug Delivery VI, Hilton Head, S.C. May 3-7, 1998, p. 385-387.
James F. Fitzgerald, et al., “Novel Coating For Improved Pulmonary Drug Delivery,” U. Of Florida Office of Graduate Research, Technology and Education, VF#1887, Jan. 15, 1998 (ABSTRACT).
David A. Edwards, et al., “Large Porous Particles for Pulmonary Drug Delivery,” Science, vol. 276, Jun. 20, 1997, p. 1868-1871.
H. Schreier, et al., “Formulation and in-vitro performance of liposome powder aerosols,” S.T.P. Pharma Sciences 4(1) 38-44, 1994.
Hans Schreier, et al., “Pulmonary delivery of liposomes,” Journal of Controlled Release, 24 (1993) 209-223.
Bulletin of the Medical School of Shanton University, 1994, vol. 2, pp. 77-78, Chinese language original and English language translation.
Powell et al., 2003, Chapter 18, Structure and Function of the Respiratory System, in Essential Medical Physiology, 3rd Edition, Leonard R. Johnson, Ed., Elsevier Academic Press, New York, pp. 259-276.
Aeorols in Medicine, 1993, pp. 72-83 and 118-156.
Osaka Pref. Hospital Pharmacist Association, “Drug Directory”, 1995, Povidone Iodine, translation of pertinent part.
Bonowitz et al., 2001, “Comparative therapeutic and toxic effects of different povidone iodine (PVP-I) formuations in a model of oral candidosis based on in vitro reconstituted epithelium,” J. Drug Targeting 9:75-83.
Brogmann et al., 1998, “Liposomal PVP-Iodine Eye Drops—A New Drug Delivery System For an Approved Active Ingredient”, Arch Pharm Med Chem 331 (Suppl. 2):52.
Damour et al, 1992, “Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes”, Berns 18 (6): 479-485.
Ganzer et al., 2001, “Efficacy and tolerability of povidone-iodine lispome complex in infected knee joints of rabbits” 11thEur Con Clin Microbiol Inf Ds, Istanbul, Turkey Apr. 2001, Clin Microiobl Inf2001; 7 Supp 1:262, Poster and Abstract.
Hauser et al., 2001, “Liposomal PVP-iodine hydrogel improves epithelialization of meshed skin grafts—evaluation of the combined effects of moisture and antisepsis,” The Plastic Surgery Research Council 46th Annual Meeting Jun. 9-12, Milwaukee, WI 36.346.
Kallengerger et al., 1991, HGY+ Med 16:383-395.
Kiss et al., 1994, “Toxic Effects of Heavy Metals on Ionic Channels”, Phama Reviews 46 (3): 245-267.
Lineaweaver et al., 1985, Arch Surg 120:257-270.
Mayer et al., 1993, “Povidone-Iodine and Wound Healing: A Critical Review”, Wounds 5(1): 14-23.
Reimer et al., 1997, “Povidone-Iodine Liposomes—An Overview,” Dermatology 195(Suppl. 2):93-99.
Reimer, et al., 2000, “In vitro and in vivo inbestigations of an innovative topical drug formulation for infection treatment and would healing: Povidone iodine lipsome hydrogen” Dermatorlogy 201:235-241, Abstract.
Reimer et al., 1999, “Povidone-iodine liposome complex—a novel anti-infective for topical treatment,” Clin. Microbial Inf. 5(Supp. 3):136, 9th European Conference of Clin. Microbiol. and Infect. Dis., Berlin, Mar. 1999, Abstract.
Reimer et al, 2000, “Povidone-Iodine Liposome Complex”, 10thEuropean Congress of Clinical Microbiology and Infectious Diseases, May 2000, Abstract.
Reimer et al, 1998, “Povidone-Iodine Liposomes—Development of a Novel Anti-Infective for Topical Treatment”, 4thInternational conference of the Hospital Infection Society, J. Hosp. Infect 40 (Supp. A), Abstract and Poster.
Stratord et al., 1983, “Effects of topically applied liposomes on disposition of epinephrine and inulin in the albirno rabbit eye” Int'l J. of Pharma 13:263-272.
Weiner et al., 1989, Drug Development and Industrial Pharmacy, 15(10):1523-1554.
Wutzler et al., 1999, “Virucidal and chlamydicidal activities of eye drops with povidone-iodine liposome complex,” Ophthalmic Res. 32:118-125.
Wutzler et al., 2001, “Virucidal activity and cytotoxicty of the liposomal formulation of povidone-iodine”, 14thInternational Conference on Antiviral Research, Apr. 200
Fleischer Wolfgang
Reimer Karen
Euro-Celtique S.A.
Jones Day
Kishore Gollamudi S.
LandOfFree
Preparations for the application of anti-inflammatory,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparations for the application of anti-inflammatory,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparations for the application of anti-inflammatory,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3844379